DWP
AMGN icon

Daymark Wealth Partners’s Amgen AMGN Stock Holding History

Daymark Wealth Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$53M Sell
150,506
-1,795
-1% -$640K 1.67% 10
2025
Q4 		$49.8M Sell
152,301
-122
-0.1% -$38.7K 1.59% 10
2025
Q3 		$43M Buy
152,423
+8,334
+6% +$2.42M 1.46% 10
2025
Q2 		$40.2M Buy
144,089
+329
+0.2% +$93.2K 1.53% 11
2025
Q1 		$44.8M Sell
143,760
-95,096
-40% -$28.1M 1.92% 10
2024
Q4 		$36.8M Buy
238,856
+7,684
+3% +$2.28M 1.56% 10
2024
Q3 		$43M Buy
231,172
+2,977
+1% +$974K 1.82% 10
2024
Q2 		$40.8M Buy
228,195
+3,299
+1% +$969K 1.87% 9
2024
Q1 		$36.2M Buy
224,896
+2,340
+1% +$685K 1.95% 9
2023
Q4 		$36M Sell
222,556
-849
-0.4% -$231K 2.21% 8
2023
Q3 		$33.8M Buy
223,405
+111,603
+100% +$27.9M 2.33% 6
2023
Q2 		$24.8M Buy
111,802
+33,869
+43% +$7.86M 1.84% 9
2023
Q1 		$18.8M Buy
77,933
+4,024
+5% +$988K 2.5% 7
2022
Q4 		$19.4M Buy
+73,909
New +$19.8M 3.43% 5

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Daymark Wealth Partners's AMGN Position: Q1 2026 in Review

Daymark Wealth Partners reduced its Amgen (AMGN) stake by 1.2% in Q1 2026, selling an estimated $640K and leaving 150,506 shares worth $53M. The position accounts for 1.67% of the portfolio, ranked #10.

Daymark Wealth Partners first reported a position in AMGN in Q4 2022 and has held it in 14 quarters since. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Daymark Wealth Partners held 150,506 shares of Amgen worth $53M as of Q1 2026.
  • Daymark Wealth Partners sold 1,795 Amgen shares in Q1 2026, an estimated $640K.
  • Amgen made up 1.67% of Daymark Wealth Partners's portfolio in Q1 2026, its #10 holding.
  • Daymark Wealth Partners first reported a position in Amgen in Q4 2022 and has held it in 14 quarters since.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Daymark Wealth Partners's 13F filing for Q1 2026, filed 11 May 2026.